Regadenoson News
Regadenoson currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Regadenoson with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: This medicinal product is for diagnostic use only. Rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (MPI) in adult...
- Evidence level: L5
- Predicted indications (20):
- anaphylaxis (99.8%)
- food-dependent exercise-induced anaphylaxis (99.7%)
- esotropia (99.1%)
- pseudoallergy (99.1%)
- headache disorder (98.0%)
- migraine disorder (97.1%)
- trigeminal autonomic cephalalgia (97.0%)
- migraine with brainstem aura (96.9%)
- bronchial disease (96.8%)
- glossodynia (95.9%)
- coccygodynia (95.8%)
- Raynaud disease (95.7%)
- endobronchial leiomyoma (95.6%)
- bronchus adenoma (95.5%)
- endobronchial lipoma (95.5%)
- atypical coarctation of aorta (95.3%)
- scalp dermatosis (95.2%)
- primary hereditary glaucoma (95.1%)
- neuralgia (95.0%)
- thrombotic disease (94.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.